Pricing Log in Create free account

Aligos Therapeutics, Inc. (ALGS) vs Genenta Science S.p.A. Unsponsored ADR (GNTA)

Aligos Therapeutics, Inc. and Genenta Science S.p.A. Unsponsored ADR are both Biotechnology companies. Aligos Therapeutics, Inc. and Genenta Science S.p.A. Unsponsored ADR are of similar size ($33.7M and $32.3M). Across the 9 metrics below, Genenta Science S.p.A. Unsponsored ADR leads on 6 and Aligos Therapeutics, Inc. on 3.

Valuation

Metric ALGS GNTA Biotechnology median
P/E n/m — 8.50
P/S 1.61 n/m 9.71
P/B 1.59 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.65 n/m 9.21
Earnings yield (150.21%) — (33.15%)
Free cash flow yield (186.46%) 0.00% (25.50%)

Profitability

Metric ALGS GNTA Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (250.63%) — 0.00%
Net margin (241.01%) — 0.00%
Free cash flow margin (299.90%) 0.00% 0.00%
Return on equity (113.59%) 0.00% (56.36%)
Return on assets (75.57%) 0.00% (48.04%)
Return on invested capital (3,379.28%) 0.00% 0.00%

Growth

Metric ALGS GNTA Biotechnology median
Revenue growth (TTM) 893.01% — 6.02%
EPS growth (last fiscal year) 88.30% 30.19% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALGS GNTA Biotechnology median
Debt to equity 0.00 0.35 0.00
Current ratio 2.19 14.16 4.72
Net debt to EBITDA 0.87 3.12 0.96

Dividend

Metric ALGS GNTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALGS GNTA Biotechnology median
Market cap 33.66m 32.28m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack